June 13th, 2022
Scilligence partners with Chemical.ai to co-develop ELN-based data integration
November 17, 2020
Scilligence Partners with CAS to Optimize R&D Informatics Workflows with Scientist-Curated Data
Scilligence Gives Back During the COVID-19 Pandemic
January 6, 2020
Scilligence and CAS Collaborate to Integrate SciFinder with ELN
December 5, 2019
Scilligence and Certara Partner to Improve Client’s Data Analysis and Visualization
Zifo RnD Solutions and Scilligence Announce Strategic Partnership
HitGen has Licensed Scilligence’s ELN and RegMol
CAMBRIDGE, Mass. and BOSTON, June 11, 2019
Scilligence and TetraScience Announce Integration Plan to Automate Research Data
Princeton University Licenses Scilligence’s Platform
The Global Health Drug Discovery Institute (GHDDI) Licenses Scilligence ELN
New York, April 12, 2019
Scilligence and Elsevier Collaborate to Enhance Lab Efficiency
Jan. 23, 2019
Scilligence Joins Accenture’s Life Sciences Research Platform Ecosystem to Help Drive Innovation in Drug Discovery and Scientific Research
Boston, November 14, 2018
Scilligence Joins Merck and Accenture During the AWS re:Invent Conference
Boston, March 21, 2018
Announcing Support for HELM 1.1 (Hierarchical Editing Language for Macromolecules) in the Open Source Web Editor
Wednesday, February 28, 2018
Scilligence EU Expansion and Beyond
Boston, June 9, 2017
Scilligence Receives ISO 27001:2013 and 9001:2015 Certifications
Boston, February 16, 2017
Biomimetic Drugs at Peking University has licensed Scilligence’s RegMol and Inventory systems
Boston, February 14, 2017
The Institute of Medicinal Plant Development has licensed Scilligence’s TouchMol4Office
Boston, February 7, 2017
The Pistoia Alliance and Scilligence Announce HELM Web Editor
January 12, 2016
Shanghai Hengrui Pharmaceutical Co., Ltd. has licensed Scilligence ELN
December 22, 2016
Shanghai Syn-The-All Pharmaceutical Co. Ltd. (STA) has licensed Scilligence ELN
August 11, 2016
Scilligence Launches New Brand Identity